SCHEMBL4255013

SCHEMBL4255013

CC(C)Oc1cccc(CN2CCC3(CC2C)C(=O)N(Cc2cc(-c4ccccc4)on2)C(=O)N3c2cccc(F)c2)c1

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 18/20 0.50
SCD O00767 1/20 0.35
IL4I1 Q96RQ9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479639 1.00 BACE1 (0.50) BACE1SCDIL4I1
SCHEMBL3479398 0.92 BACE1 (0.47) BACE1
SCHEMBL3479522 0.91 BACE1 (0.52) BACE1
SCHEMBL4253964 0.91 BACE1 (0.52) BACE1
SCHEMBL3479493 0.88 BACE1 (0.49) BACE1
SCHEMBL3479469 0.88 BACE1 (0.53) BACE1
SCHEMBL3479492 0.87 BACE1 (0.57) BACE1
SCHEMBL3479513 0.87 BACE1 (0.51) BACE1
SCHEMBL3479440 0.86 BACE1 (0.52) BACE1
SCHEMBL3479541 0.86 BACE1 (0.52) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2063889-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck & Co., Inc. (US) 2009-06-03 EP claimed
WO-2008030412-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2008-03-13 WO claimed